ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine...

  • Main
  • 2017 / 12
  • ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine...

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA

Taiwo, Babafemi O, Zheng, Lu, Stefanescu, Andrei, Nyaku, Amesika, Bezins, Baiba, Wallis, Carole L, Godfrey, Catherine, Sax, Paul E, Acosta, Edward, Haas, David, Smith, Kimberly Y, Sha, Beverly, Van Da
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/cix1083
Date:
December, 2017
File:
PDF, 726 KB
english, 2017
Conversion to is in progress
Conversion to is failed